NCT06286085 A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma
| NCT ID | NCT06286085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Portsmouth Hospitals NHS Trust |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-02-27 |
| Primary Completion | 2027-05-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-02-27 with a primary completion date of 2027-05-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess the concordance of international asthma guidelines in the diagnosis of asthma and explore the presence of airways disease using additional non-guideline physiologic criteria, such as IOS (impulse osciollometry), not included in the guidelines, but available in the Portsmouth lung function service.
Eligibility Criteria
Inclusion Criteria: * The patient will meet all the following criteria to be considered eligible for the study: * Aged 18 years or over. * All patients who have attended full asthma workups from November 2021 till date * Willing and able to consent to use their data in this study (opt-out form or e-consent). * Patients referred to the Portsmouth asthma service for diagnosis and further management of presumed asthma. Comorbidities are common in asthma, thus patients with co-existing conditions such as obesity, bronchiectasis or COPD will be included. Exclusion Criteria: * The participant may not enter the study if either of the following apply: * Unable to comprehend the study and provide informed consent, e.g., insufficient command of English in the absence of someone who can adequately interpret. * Patients with other primary respiratory conditions, such as ILD.
Contact & Investigator
Anoop Chauhan
PRINCIPAL INVESTIGATOR
Portsmouth University Hospital Trust
Frequently Asked Questions
Who can join the NCT06286085 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06286085 currently recruiting?
Yes, NCT06286085 is actively recruiting participants. Contact the research team at celia.selvin-premkumar@porthosp.nhs.uk for enrollment information.
Where is the NCT06286085 trial being conducted?
This trial is being conducted at Portsmouth, United Kingdom.
Who is sponsoring the NCT06286085 clinical trial?
NCT06286085 is sponsored by Portsmouth Hospitals NHS Trust. The principal investigator is Anoop Chauhan at Portsmouth University Hospital Trust. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.